Daeun You

575 total citations
22 papers, 438 citations indexed

About

Daeun You is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Daeun You has authored 22 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Immunology and Allergy. Recurrent topics in Daeun You's work include HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cell Adhesion Molecules Research (4 papers). Daeun You is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cell Adhesion Molecules Research (4 papers). Daeun You collaborates with scholars based in South Korea, Sweden and Switzerland. Daeun You's co-authors include Sangmin Kim, Jeong Eon Lee, Yisun Jeong, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Myeongjin Jeon, Sun Young Yoon, Soo Youn Bae and Jeonghun Han and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and European Journal of Pharmacology.

In The Last Decade

Daeun You

21 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daeun You South Korea 12 213 159 94 85 54 22 438
Yisun Jeong South Korea 10 179 0.8× 129 0.8× 86 0.9× 65 0.8× 40 0.7× 21 361
Zujun Que China 16 251 1.2× 155 1.0× 56 0.6× 134 1.6× 75 1.4× 35 551
Myeongjin Jeon South Korea 13 235 1.1× 151 0.9× 105 1.1× 101 1.2× 59 1.1× 16 470
Chunjie Wen China 15 316 1.5× 105 0.7× 60 0.6× 162 1.9× 48 0.9× 29 519
Hong Xin United States 12 224 1.1× 105 0.7× 87 0.9× 49 0.6× 29 0.5× 17 496
Haibo Cheng China 14 313 1.5× 98 0.6× 44 0.5× 113 1.3× 49 0.9× 31 576
Poulami Khan India 11 334 1.6× 210 1.3× 38 0.4× 143 1.7× 40 0.7× 15 542
Andrea Mancini Italy 16 384 1.8× 316 2.0× 105 1.1× 85 1.0× 107 2.0× 33 729
Liuqi Yang China 7 284 1.3× 138 0.9× 32 0.3× 132 1.6× 20 0.4× 11 451
Xiaoli Liao China 13 238 1.1× 110 0.7× 32 0.3× 120 1.4× 74 1.4× 29 426

Countries citing papers authored by Daeun You

Since Specialization
Citations

This map shows the geographic impact of Daeun You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daeun You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daeun You more than expected).

Fields of papers citing papers by Daeun You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daeun You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daeun You. The network helps show where Daeun You may publish in the future.

Co-authorship network of co-authors of Daeun You

This figure shows the co-authorship network connecting the top 25 collaborators of Daeun You. A scholar is included among the top collaborators of Daeun You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daeun You. Daeun You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Chan-Yong, Wanyoung Lim, Jeonghun Han, et al.. (2024). Efficient separation of large particles and giant cancer cells using an isosceles trapezoidal spiral microchannel. The Analyst. 149(17). 4496–4505. 1 indexed citations
2.
Jeong, Yisun, Hyungjoo Kim, Daeun You, et al.. (2024). Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer. Cells. 14(1). 19–19. 1 indexed citations
3.
You, Daeun, Hyungjoo Kim, Yisun Jeong, et al.. (2023). Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages. International Journal of Molecular Sciences. 24(2). 1443–1443. 8 indexed citations
5.
You, Daeun, et al.. (2023). Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/Src Pathway in HER2-positive Breast Cancer Cells. Anticancer Research. 43(3). 1079–1089. 2 indexed citations
6.
Kim, Sangmin, et al.. (2022). Celastrol attenuates amphiregulin expression by inhibiting MAPK signaling pathway in triple-negative breast cancer cells. Phytomedicine Plus. 2(3). 100319–100319. 2 indexed citations
7.
You, Daeun, Yisun Jeong, Sun Young Yoon, et al.. (2021). Entelon® (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells. Molecules. 26(12). 3644–3644. 9 indexed citations
8.
Kim, Sangmin, Daeun You, Yisun Jeong, et al.. (2021). Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells. European Journal of Pharmacology. 895. 173868–173868. 15 indexed citations
9.
Kim, Sangmin, Daeun You, Yisun Jeong, et al.. (2021). Inhibition of platelet‑derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor α positive breast cancer. Oncology Letters. 21(4). 294–294. 10 indexed citations
10.
Kim, Sangmin, Daeun You, Yisun Jeong, et al.. (2020). WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells. Cytokine. 135. 155213–155213. 9 indexed citations
11.
Jeong, Yisun, Soo Youn Bae, Daeun You, et al.. (2019). EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer. Cellular Physiology and Biochemistry. 53(5). 805–819. 32 indexed citations
12.
13.
Kim, Sangmin, Daeun You, Yisun Jeong, et al.. (2018). Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells. Phytomedicine. 50. 43–49. 66 indexed citations
14.
Kim, Sangmin, Jeongmin Lee, Daeun You, et al.. (2018). Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells. Cellular Physiology and Biochemistry. 45(2). 795–807. 56 indexed citations
15.
Lim, Wanyoung, Daeun You, Jeonghun Han, et al.. (2018). Formation of size-controllable tumour spheroids using a microfluidic pillar array (μFPA) device. The Analyst. 143(23). 5841–5848. 18 indexed citations
16.
Jeong, Yisun, Daeun You, Hyungu Kang, et al.. (2018). Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells. Journal of Breast Cancer. 21(1). 21–21. 22 indexed citations
17.
Kim, Sangmin, Daeun You, Yisun Jeong, et al.. (2018). TP53 upregulates α‑smooth muscle actin expression in tamoxifen‑resistant breast cancer cells. Oncology Reports. 41(2). 1075–1082. 14 indexed citations
18.
You, Daeun, Seung Pil Jung, Yisun Jeong, et al.. (2017). Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells. BMB Reports. 50(12). 615–620. 20 indexed citations
19.
You, Daeun, Seung Pil Jung, Yisun Jeong, Soo Youn Bae, & Sangmin Kim. (2017). Wild-type p53 controls the level of fibronectin expression in breast cancer cells. Oncology Reports. 38(4). 2551–2557. 7 indexed citations
20.
Kim, Sangmin, Jeonghun Han, Myeongjin Jeon, et al.. (2016). Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression. Tumor Biology. 37(8). 11397–11407. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026